Answers are grounded in this paper and cite their sources.
This interventional clinical study aimed to assess the efficacy of the oral intake of a food supplement containing 200 mg sodium hyaluronate (SH) as adjuvant of the radiofrequency (RF) and radioporation (RP) treatment in menopausal women suffering of vulvovaginal atrophy. The study was carried out in thirty menopausal patients with diagnosis of vulvovaginal atrophy who underwent radiofrequency and radioporation treatments. Half of the test subjects received the test food supplement. The primary outcome was the improvement in vaginal functional wellbeing while the secondary endpoint related to the persistence of vaginal atrophy symptoms. Sodium hyaluronate was effective in improving (p<0.001) the vaginal healthy status and in decreasing (p<0.001) the persistence of vaginal atrophy symptoms both during the treatment and at the followup. The study results demonstrated the clinical relevance of the SH intake in improving the vaginal symptoms during the RF/ RP treatment, a prolongation of the benefits achieved at the end of the RF/RP treatment, and in maintaining the hydration of vagina. In conclusion SH intake can be a valid support in improving the vaginal functional wellbeing, in delaying the recurrence of vaginal atrophy symptomatology when administered in combination with the FR/RP treatment, and in preventing the relapse of vulvovaginal atrophy.
No takes yet. Share an insight, caveat, or question.
Nobile et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: